Detection of septic transfusion reactions to platelet transfusions by active and passive surveillance

Hong Hong1, Wenbin Xiao1, Hillard M Lazarus1

  • 1Departments of Pathology and Medicine, University Hospitals Case Medical Center and Case Western Reserve University School of Medicine, Cleveland, OH.

Blood
|November 25, 2015
PubMed

Insights

Bacterial contamination in platelets causes septic transfusion reactions (STRs), especially in neutropenic patients. Current passive surveillance and STR criteria fail to reliably detect these dangerous reactions.

Area of Science:

  • Transfusion Medicine
  • Infectious Disease
  • Hematology

Background:

  • Septic transfusion reactions (STRs) are a significant risk associated with platelet transfusions due to bacterial contamination.
  • Despite interventions, bacterial contamination of platelets remains a concern.
  • Existing surveillance methods and diagnostic criteria for STRs have limitations.

Purpose of the Study:

  • To evaluate the effectiveness of active and passive surveillance for detecting bacterially contaminated platelets.
  • To assess the sensitivity and specificity of various criteria for diagnosing STRs.
  • To identify patient populations at higher risk for STRs.

Main Methods:

  • Conducted a 7-year study (2007-2013) involving culture of platelet aliquots and review of reported transfusion reactions.
  • Utilized active surveillance (platelet cultures) and passive surveillance (reported reactions).
  • Evaluated five sets of STR criteria, including AABB criteria, for sensitivity and specificity.

Main Results:

  • Active surveillance identified 20 bacterially contaminated platelet units (0.004%) leading to 5 STRs in neutropenic patients.
  • Passive surveillance failed to report any of the identified STRs.
  • Reported transfusion reactions often met STR criteria non-specifically, with low sensitivity (5.1%-45.5%) for established criteria.

Conclusions:

  • Bacterial contamination of platelets continues to cause STRs, particularly in neutropenic patients.
  • Passive surveillance is inadequate for detecting STRs, and current STR criteria lack specificity.
  • Further measures like secondary testing or pathogen reduction technologies are needed to improve platelet safety.